Research
FORUM TRANSCRIPT

Ambu – Single-use Endoscope Product Positioning, Portfolio Expansion & Growth Outlook

  • Public Equity
  • Healthcare
  • Europe
PREMIUM

Specialist

Former senior executive at Ambu AS

Agenda

  • Pandemic tailwinds for single-use endoscopes vs reusable products and FDA innovation push
  • Post-pandemic outlook on single-use uptake across specialties such as bronchology and ENT (ear, nose and throat)
  • Ambu’s (CSE: AMBU B) portfolio expansion, assessing new product releases such as the aScope 5 Broncho
  • Financial performance across geographies, discussing cost-reduction programme and Mexico facility build-out
  • Competitive positioning of Ambu’s single-use products vs those of Boston Scientific (NYSE: BSX) and Olympus (TYO: 7733)

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo